Roflair Tablet
₹112.5*
MRP ₹125
10% off
₹106*
MRP ₹125
15% CB
₹19 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Roflair Tablet is a respiratory medicine that belongs to the class of 'phosphodiesterase inhibitors' primarily used to manage chronic obstructive pulmonary disease (COPD). Chronic obstructive pulmonary disease is a group of progressive lung diseases. It is a long-term condition which makes you hard to take breathe. People with COPD have emphysema and chronic bronchitis. Emphysema destroys air sacs in the lungs, which interferes with the movement of outward airflow. Bronchitis allows mucus to build up in the bronchial tubes by causing inflammation and narrowing of the tubes.
Roflair Tablet contains Roflumilast, which helps in the treatment of chronic obstructive pulmonary disease (COPD). Roflumilast works by relaxing the airway in the lungs and making it easier to breathe. In addition to this, Roflumilast also helps treat the symptoms. It is generally a long-term treatment.
Take Roflair Tablet with or without food or as directed by your doctor. It should be swallowed whole with a glass of water. Do not chew, bite, or break it. Your doctor will advise you how often you take your tablets based on your medical condition. You may experience diarrhoea, nausea, stomach ache, weight decrease and headache in some cases. Most of these side effects of Roflair Tablet do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor.
Try not to stop taking this medicine on your own. Do not stop taking Roflair Tablet despite symptomatic relief. Treat your condition effectually, continue taking Roflair Tablet for as long as it has been prescribed for you. Do not take this medicine if you have any moderate or severe liver problems. Consult your doctor before taking Roflair Tablet if you are a pregnant or breastfeeding woman. Avoid consuming alcohol along with Roflair Tablet. Roflair Tablet is not recommended for use in children and adolescents under 18 years of age.
Roflair Tablet contains Roflumilast, which helps in the treatment of chronic obstructive pulmonary disease (COPD). Roflumilast works by relaxing the airway in the lungs and making it easier to breathe. In addition to this, roflumilast also helps treat the symptoms. It is generally a long-term treatment.
Do not use Roflair Tablet in more than the prescribed doses, leading to severe heart or lung problems. After taking Roflair Tablet, if you experience irregular heartbeats, leg cramps, muscle weakness, numbness or tingling, or suicidal thinking and behaviour, please consult a doctor immediately. If you have cancer, heart disease, depression, inform your doctor before taking Roflair Tablet. This medicine is recommended for use in children and adolescents under 18 years of age. Before taking Roflair Tablet, inform your doctor if you are already on medications like theophylline, oral corticosteroids, methotrexate, enoxacin or cimetidine.
Drug-Drug Interactions: Roflair Tablet interacts with medicine used to treat allergic disorders (methylprednisolone), a drug used to treat asthma (budesonide/formoterol), drugs used to treat seizures (carbamazepine, phenytoin)
Drug-Food Interactions: Avoid alcohol consumption while taking Roflair Tablet as it could lead to increased dizziness.
Drug-Disease Interactions: Roflair Tablet should be taken with caution if you have a hepatic impairment, depression and weight loss.
COPD: It is a group of progressive lung diseases, most commonly emphysema (shortness of breath) and chronic bronchitis (inflammation and irritation of bronchial tubes). Initially, it may be mild, but it can lead to total blockage of airways and damage the lungs in severe cases. The major cause of COPD is smoking tobacco and exposure to air pollutants like asbestos and chemicals/fumes. Also, long-term exposure to fumes and chemicals may lead to COPD. The symptoms include chronic cough, shortness of breath or wheezing (whistle sound while breathing).
Country of origin
Manufacturer/Marketer address
Alcohol
Caution
The interaction of Roflair Tablet with alcohol is unknown. Please consult a doctor before consuming alcohol with Roflair Tablet.
Pregnancy
Caution
The safety of Roflair Tablet in pregnant women is unknown and is given to pregnant women only if the doctor thinks benefits outweigh risks.
Breast Feeding
Caution
It is unknown whether Roflair Tablet is excreted in human milk. It is given to breastfeeding mothers only if the doctor thinks benefits are greater than risks.
Driving
Unsafe
Roflair Tablet may cause blurred vision or dizziness in some people. Therefore, avoid driving if you notice any changes in vision or feel dizzy after taking Roflair Tablet.
Liver
Caution
Do not take Roflair Tablet if you have moderate or severe liver problems. Roflair Tablet should be used with caution in patients with liver disease. Dose adjustment of Roflair Tablet may be needed. Please consult your doctor.
Kidney
Safe if prescribed
If you have any concerns regarding the use of Roflair Tablet in patients with kidney problems, please consult a doctor.
Children
Unsafe
Roflair Tablet should not be used in children and adolescents under 18 years of age.
Product Substitutes